David Buck

24.5k total citations · 4 hit papers
66 papers, 9.1k citations indexed

About

David Buck is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Buck has authored 66 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 30 papers in Immunology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Buck's work include T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (16 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). David Buck is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (16 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). David Buck collaborates with scholars based in United Kingdom, United States and Germany. David Buck's co-authors include Sheri Miraglia, Graça Almeida‐Porada, Johanna Olweus, A G Leary, Makio Ogawa, Esmail D. Zanjani, John F. Kearney, Michael J. Reitsma, Anna Masek and Ann Tsukamoto and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

David Buck

65 papers receiving 8.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells

1997 1.4k citations Sheri Miraglia, David Buck et al. profile →
Direct isolation of human central nervous system stem cells

2000 1.4k citations David Buck, Dongping He et al. Proceedings of the National Academy of Sciences profile →
BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood

2000 1.0k citations David Buck et al. The Journal of Immunology profile →
A Novel Five-Transmembrane Hematopoietic Stem Cell Antigen: Isolation, Characterization, and Molecular Cloning

1997 779 citations Sheri Miraglia, David Buck et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David Buck	3.7k	3.0k	2.5k	1.1k	800	66	9.1k
Hilmar Lemke	3.4k 0.9×	3.6k 1.2×	3.4k 1.4×	1.2k 1.1×	1.3k 1.6×	74	12.2k
Joachim W. Ellwart	4.2k 1.1×	4.6k 1.5×	3.7k 1.5×	486 0.4×	1.2k 1.5×	87	11.1k
David Y. Mason	3.4k 0.9×	4.5k 1.5×	2.6k 1.1×	1.5k 1.3×	699 0.9×	183	12.7k
Hisamaru Hirai	9.1k 2.5×	3.6k 1.2×	3.2k 1.3×	1.4k 1.2×	1.2k 1.5×	302	17.1k
Boris Fehse	5.1k 1.4×	1.5k 0.5×	2.7k 1.1×	1.1k 1.0×	508 0.6×	252	9.2k
Anne Wilson	4.8k 1.3×	5.0k 1.7×	1.9k 0.8×	1.0k 0.9×	833 1.0×	117	10.6k
Ofer Lider	2.8k 0.8×	4.4k 1.5×	1.8k 0.7×	615 0.5×	731 0.9×	130	10.2k
Ulrich Schwab	2.2k 0.6×	1.4k 0.5×	2.1k 0.9×	674 0.6×	1.1k 1.4×	32	7.3k
Ashley R. Dunn	3.6k 1.0×	4.9k 1.6×	2.0k 0.8×	545 0.5×	514 0.6×	101	10.0k
Yuan Zhuang	8.7k 2.3×	3.3k 1.1×	1.4k 0.6×	420 0.4×	957 1.2×	188	12.9k

Countries citing papers authored by David Buck

Since Specialization

Citations

This map shows the geographic impact of David Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Buck more than expected).

Fields of papers citing papers by David Buck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Buck. The network helps show where David Buck may publish in the future.

Co-authorship network of co-authors of David Buck

This figure shows the co-authorship network connecting the top 25 collaborators of David Buck. A scholar is included among the top collaborators of David Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Buck. David Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kooblall, Kreepa, Mark Stevenson, Raphael Heilig, et al.. (2024). Identification of cellular retinoic acid binding protein 2 (CRABP2) as downstream target of nuclear factor I/X (NFIX): implications for skeletal dysplasia syndromes. JBMR Plus. 8(7). ziae060–ziae060. 1 indexed citations

Jansen, Kathrin, Moustafa Attar, Stefano Maio, et al.. (2021). RBFOX splicing factors contribute to a broad but selective recapitulation of peripheral tissue splicing patterns in the thymus. Genome Research. 31(11). 2022–2034. 6 indexed citations

Attar, Moustafa, Eshita Sharma, Shuqiang Li, et al.. (2018). A practical solution for preserving single cells for RNA sequencing. Scientific Reports. 8(1). 2151–2151. 47 indexed citations

Lines, Kate E, Mark Stevenson, P. Filippakopoulos, et al.. (2017). Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors. Oncogenesis. 6(5). e332–e332. 39 indexed citations

Green, Angela, Gerton Lunter, Christiana Kartsonaki, et al.. (2015). High-throughput DNA Sequencing Identifies Novel CtIP (RBBP8) Variants in Muscle-invasive Bladder Cancer Patients. Bladder Cancer. 1(1). 31–44. 1 indexed citations

Giannoulatou, Eleni, Gil McVean, Indira B. Taylor, et al.. (2013). Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline. Proceedings of the National Academy of Sciences. 110(50). 20152–20157. 58 indexed citations

Nesbit, M. Andrew, Fadil Hannan, Sarah Howles, et al.. (2012). Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nature Genetics. 45(1). 93–97. 177 indexed citations

Eyre, David W., Tanya Golubchik, N Claire Gordon, et al.. (2012). A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open. 2(3). e001124–e001124. 192 indexed citations

Parkinson, Nick, Siarhei Maslau, Gang Zhang, et al.. (2011). Preparation of high-quality next-generation sequencing libraries from picogram quantities of target DNA. Genome Research. 22(1). 125–133. 48 indexed citations

10.

Buck, David, et al.. (2004). I-95 shutdown-coordinating transportation and emergency response. Public roads. 68(2). 42–51. 3 indexed citations

11.

Corbeil, Denis, Katja Röper, Andrea Hellwig, et al.. (2000). The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions. Journal of Biological Chemistry. 275(8). 5512–5520. 357 indexed citations

12.

Uchida, Naoyuki, Dongping He, Michael J. Reitsma, et al.. (1999). Direct isolation of human neural stem cells from fetal brain by cell sorting. The Society for Neuroscience Abstracts. 25. 1767. 3 indexed citations

13.

Schweighoffer, Tamás, Yoichiro Tanaka, Mark Tidswell, et al.. (1993). Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism.. The Journal of Immunology. 151(2). 717–729. 230 indexed citations

14.

Azuma, Miyuki, Mark J. Cayabyab, David Buck, Joseph H. Phillips, & Lewis L. Lanier. (1992). CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.. The Journal of Experimental Medicine. 175(2). 353–360. 297 indexed citations

15.

Schockmel, Gérard A., Chamorro Somoza, David Buck, et al.. (1992). Antibody and HIV-1 gpl20 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature. 358(6381). 76–79. 65 indexed citations

16.

Healey, Don, L Dianda, John P. Moore, et al.. (1990). Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.. The Journal of Experimental Medicine. 172(4). 1233–1242. 197 indexed citations

17.

Attanasio, Roberta, Ronald C. Kennedy, Jonathan S. Allan, et al.. (1990). Anti-idiotypic antibodies of a predefined specificity generated against cdrsvn synthetic peptides define a private anti-CD4 idiotype. Molecular Immunology. 27(6). 513–522. 15 indexed citations

18.

Lanier, Lewis L., et al.. (1988). Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.. The Journal of Experimental Medicine. 167(5). 1572–1585. 224 indexed citations

19.

Buck, David, Walter F. Bodmer, Martin Bobrow, & Uta Francke. (1976). The gene for the species antigen on human chromosome 11 is on the short arm. Cytogenetic and Genome Research. 16(1-5). 97–98. 10 indexed citations

20.

Buck, David, S.J. Goss, & Walter F. Bodmer. (1976). Regional mapping of the X-linked gene for a human cell surface antigen, SA-X. Cytogenetic and Genome Research. 16(1-5). 99–100. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact